) eDWI with biexponential model using the correlative analysis of incoherent intravoxel motion (IVIM) and dynamic contrast enhancement (DCE) in MR imaging of brain gliomas.
Methods:
For 92 cases with pathologically confirmed gliomas
the combined protocol of conventional MRI
DWI
eDWI
DCE-MRI was performed. The following parameters on tumor regions were measured including eDWI derived parameters ofDslow
Dfast and PF and DCE-derived parameters of volume transfer constant (Ktrans)
extravascular extracellular space volume fraction (Ve)
Kep and fraction plasma volume (Vp). According to 2007 central nervous system World Health Organization (WHO) classification
92 gliomas were classified into groups of high-grade glioma (HGG; grade Ⅲ+Ⅳ) and low-grade glioma (LGG; grade Ⅱ); glioblastoma multiforme (GBM; grade Ⅳ) and other grade glioma (OGG; grade Ⅱ+Ⅲ). Correlative analyses were performed between perfusion-related parameters of Dfast and PF and perfusion parameters of Ktrans
Ve
Vp and Kep. Meanwhile
comparisons of multiple parameters were made for HGG vs. LGG and GBM vs. OGG
as well as receiver operating characteristic (ROC) curve analyses to discriminate HGG from LGG and GBM from OGG.
Results:
Positive correlations were observed for Dfast with parameters of Ktrans
Ve and Vp with
values of 0.396
0.460 and 0.412 (all
P
0.01)
respectively
but no correlation between Dfast and Kep. There were negative correlations between PF and parameters of Ktrans
Ve and Vp with
values of -0.323 and -0.319
respectively
all
P
0.05)
and no significant correlation between PF and Kep. Other than Kep
there were significant diffe
rences for the remaining parameters between HGG and LGG
between GBM and OGG. ROC analyses showed the maximal area under curve (AUC) values of 0.808 for Ktrans to identify HGG from LGG and 0.802 for Dfast to discriminate GBM from OGG
respectively.
Conclusion:
There are close correlations between IVIM and DCE in MR imaging of tumor perfusion of brain gliomas. As a potential candidate biomarker
it is hopeful for Dfast to evaluate the characteristics of tumor microvascular perfusion without exogenous contrast tracker.